Results

eNauka >  Results >  Efficacy and safety of subcutaneous rituximab versus intravenous rituximab for first-line treatment of follicular lymphoma (SABRINA): a randomised, open-label, phase 3 trial
Title: Efficacy and safety of subcutaneous rituximab versus intravenous rituximab for first-line treatment of follicular lymphoma (SABRINA): a randomised, open-label, phase 3 trial
Authors: Davies, Andrew; Merli, Francesco; Mihaljevic, Biljana S ; Mercadal, Santiago; Siritanaratkul, Noppadol; Solal-Celigny, Philippe; Boehnke, Axel; Berge, Claude; Genevray, Magali; Zharkov, Artem;
Dixon, Mark; Brewster, Michael; Barrett, Martin; MacDonald, David;
Issue Date: 2017
Publication: LANCET HAEMATOLOGY
ISSN: 2352-3026 Lancet Haematology Search Idenfier
Type: Article
Collation: vol. 4 br. 6 str. e272-e282
DOI: 10.1016/S2352-3026(17)30078-9
WoS-ID: 000405452100012
Scopus-ID: 2-s2.0-85018982291
URI: https://enauka.gov.rs/handle/123456789/830157
Project: F Hoffmann-La Roche
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
21a+M21a+

107
SCOPUSTM
77
OpenCitations
101
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.